Givaudan, CH0010645932

Givaudan reports 8.6 percent growth and Givaudan stock costs EUR 4,248.00

Published on 10/27/2026 at 10:55 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Nine-month sales reached CHF 5.89 billion, with 5.20 percent like-for-like growth. Givaudan stock costs EUR 4,248.00 on October 27, 2026.

Sales growth and analyst caution

  • Third-quarter like-for-like sales grew 8.60 percent on October 13, 2026.
  • Fragrance and Beauty sales rose 13.50 percent in the third quarter of 2026.
  • Givaudan stock traded at EUR 4,248.00 at 10:46 a.m. CEST at Lang & Schwarz on October 27, 2026.
  • Bernstein maintained a Sell rating with a CHF 2,886.00 target on October 9, 2026.
Givaudan, CH0010645932, Illustration mit AI erstellt.

Givaudan (ISIN CH0010645932) was trading at EUR 4,248.00 at Lang & Schwarz on October 27, 2026 at 10:46 a.m. CEST as Yahoo Finance reported the company's 8.60 percent like-for-like sales growth in the third quarter. The result keeps the fragrance business at the center of the investment case.

Three dated signals for Givaudan

On October 9, 2026, The Globe and Mail reported that Bernstein maintained a Sell rating and a CHF 2,886.00 price target. On October 13, 2026, Givaudan reported nine-month sales of CHF 5.89 billion, up 5.20 percent like for like, through a report carried by FashionNetwork. On October 27, 2026, the Lang & Schwarz quote stood at EUR 4,248.00 during trading.

What drives the sales split?

Fragrance and Beauty supplied the strongest operating signal: third-quarter sales increased 13.50 percent, compared with 3.50 percent for Taste & Wellbeing, according to Yahoo Finance. Fine Fragrance sales rose 15.30 percent in the first nine months, while Taste & Wellbeing delivered 1.50 percent like-for-like growth. The contrast makes fragrance demand the clearest near-term earnings driver, while food ingredients remain the weaker side of the portfolio.

Dates that shape the next view

Givaudan's next scheduled investor presentation is October 29, 2026, according to the company's investor page. Full-year results are scheduled for January 27, 2027, as reported by Yahoo Finance. The dates give investors a defined timetable for testing whether the third-quarter acceleration can continue.

Price and analyst caution

Givaudan's nine-month sales growth exceeded the 3.90 percent consensus cited by MarketScreener. The same report said Jefferies retained a Hold rating with a CHF 3,030.00 target, while Bernstein kept its CHF 2,886.00 target. The split between stronger operating growth and cautious valuation views remains the key tension around the stock.

Givaudan stock in trading

Givaudan stock was trading at EUR 4,248.00 at Lang & Schwarz on October 27, 2026 at 10:46 a.m. CEST.

The further course of trading is shown by the continuously updated real-time quote of Givaudan stock.

Givaudan stock facts

  • Company: Givaudan S.A.
  • ISIN: CH0010645932
  • Ticker: GIVN
  • Primary exchange: SIX Swiss Exchange
  • Price Lang & Schwarz (as of October 27, 2026, 10:46 a.m. CEST): EUR 4,248.00
  • Market capitalization: CHF 36.2 billion (as of October 27, 2026)
  • 52-week range: CHF 2,566.00-4,015.00 (as of October 27, 2026)
  • Sector / Industry: Basic Materials / Specialty Chemicals
  • Index membership: SMI

Market context: Market report SMI.

More news and analyses on Givaudan stock

Disclaimer...
en | CH0010645932 | GIVAUDAN | boerse | 70419230 |